Should newborn genetic testing for autism be introduced?

Area of Science:

• Genetics
• Developmental Pediatrics
• Public Health Policy

Background:

• Genetic testing is advancing, raising questions about its application in early childhood conditions like autism.
• Current genetic testing for autism has benefits and limitations, including variable gene penetrance and phenotypic heterogeneity.
• The state's role in facilitating and subsidizing genetic testing, particularly for newborns, is under consideration.

Purpose of the Study:

• To review the potential role of newborn genetic testing for autism.
• To examine the state's responsibility in facilitating and subsidizing such testing.
• To compare newborn genetic testing with diagnostic genetic testing for parental decision-making.

Main Methods:

• Literature review of current genetic testing benefits and limitations.
• Analysis of potential benefits of presymptomatic autism genetic testing.
• Evaluation of limitations including penetrance, heterogeneity, access to treatment, psychological harm, and cost.

Main Results:

• Presymptomatic newborn genetic testing could enable earlier diagnosis and intervention, improving outcomes.
• Limitations include variable gene penetrance, autism's phenotypic diversity, treatment access issues, caregiver psychological impact, and financial concerns.
• Diagnostic genetic testing is proposed as a more beneficial alternative for understanding recurrence risks and informing reproductive choices.

Conclusions:

• Facilitating diagnostic genetic testing, with financial and infrastructural support, is recommended over widespread newborn genetic testing for autism.
• Support should include subsidies, testing facilities, and trained personnel for pre- and post-genetic test counseling.
• This approach better addresses parental needs for reproductive decision-making and understanding genetic conditions.